Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 50

    1.

    Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).

    Osorio A, Milne RL, Pita G, Peterlongo P, Heikkinen T, Simard J, Chenevix-Trench G, Spurdle AB, Beesley J, Chen X, Healey S; KConFab, Neuhausen SL, Ding YC, Couch FJ, Wang X, Lindor N, Manoukian S, Barile M, Viel A, Tizzoni L, Szabo CI, Foretova L, Zikan M, Claes K, Greene MH, Mai P, Rennert G, Lejbkowicz F, Barnett-Griness O, Andrulis IL, Ozcelik H, Weerasooriya N; OCGN, Gerdes AM, Thomassen M, Cruger DG, Caligo MA, Friedman E, Kaufman B, Laitman Y, Cohen S, Kontorovich T, Gershoni-Baruch R, Dagan E, Jernström H, Askmalm MS, Arver B, Malmer B; SWE-BRCA, Domchek SM, Nathanson KL, Brunet J, Ramón Y Cajal T, Yannoukakos D, Hamann U; HEBON, Hogervorst FB, Verhoef S, García EG, Wijnen JT, van den Ouweland A; EMBRACE, Easton DF, Peock S, Cook M, Oliver CT, Frost D, Luccarini C, Evans DG, Lalloo F, Eeles R, Pichert G, Cook J, Hodgson S, Morrison PJ, Douglas F, Godwin AK; GEMO, Sinilnikova OM, Barjhoux L, Stoppa-Lyonnet D, Moncoutier V, Giraud S, Cassini C, Olivier-Faivre L, Révillion F, Peyrat JP, Muller D, Fricker JP, Lynch HT, John EM, Buys S, Daly M, Hopper JL, Terry MB, Miron A, Yassin Y, Goldgar D; Breast Cancer Family Registry, Singer CF, Gschwantler-Kaulich D, Pfeiler G, Spiess AC, Hansen TV, Johannsson OT, Kirchhoff T, Offit K, Kosarin K, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV, Toland AE, Montagna M, Casella C, Imyanitov EN, Allavena A, Schmutzler RK, Versmold B, Engel C, Meindl A, Ditsch N, Arnold N, Niederacher D, Deissler H, Fiebig B, Varon-Mateeva R, Schaefer D, Froster UG, Caldes T, de la Hoya M, McGuffog L, Antoniou AC, Nevanlinna H, Radice P, Benítez J; CMBA.

    Br J Cancer. 2009 Dec 15;101(12):2048-54. Epub 2009 Nov 17.PMID: 19920816 [PubMed - in process]Related articles

    2.

    Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2.

    Domchek SM, Gaudet MM, Stopfer JE, Fleischaut MH, Powers J, Kauff N, Offit K, Nathanson KL, Robson M.

    Breast Cancer Res Treat. 2009 Nov 3. [Epub ahead of print]PMID: 19885732 [PubMed - as supplied by publisher]Related articles

    3.

    Homeostasis of peripheral FoxP3(+) CD4 (+) regulatory T cells in patients with early and late stage breast cancer.

    Rech AJ, Mick R, Kaplan DE, Chang KM, Domchek SM, Vonderheide RH.

    Cancer Immunol Immunother. 2009 Oct 24. [Epub ahead of print]PMID: 19855964 [PubMed - as supplied by publisher]Related articles

    4.

    Breast cancer gene variants: separating the harmful from the harmless.

    Domchek SM, Greenberg RA.

    J Clin Invest. 2009 Oct;119(10):2895-7. doi: 10.1172/JCI40577. Epub 2009 Sep 21.PMID: 19770511 [PubMed - in process]Related articles

    5.

    The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.

    Sinilnikova OM, Antoniou AC, Simard J, Healey S, Léoné M, Sinnett D, Spurdle AB, Beesley J, Chen X; kConFab, Greene MH, Loud JT, Lejbkowicz F, Rennert G, Dishon S, Andrulis IL; OCGN, Domchek SM, Nathanson KL, Manoukian S, Radice P, Konstantopoulou I, Blanco I, Laborde AL, Durán M, Osorio A, Benitez J, Hamann U, Hogervorst FB, van Os TA, Gille HJ; HEBON, Peock S, Cook M, Luccarini C, Evans DG, Lalloo F, Eeles R, Pichert G, Davidson R, Cole T, Cook J, Paterson J, Brewer C; EMBRACE, Hughes DJ, Coupier I, Giraud S, Coulet F, Colas C, Soubrier F, Rouleau E, Bièche I, Lidereau R, Demange L, Nogues C, Lynch HT; GEMO, Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Sutter C, Deissler H, Schaefer D, Froster UG; GC-HBOC, Aittomäki K, Nevanlinna H, McGuffog L, Easton DF, Chenevix-Trench G, Stoppa-Lyonnet D; Consortium of Investigators of Modifiers of BRCA1/2.

    Br J Cancer. 2009 Oct 20;101(8):1456-60. Epub 2009 Aug 25.PMID: 19707196 [PubMed - indexed for MEDLINE]Related articles

    6.

    Multimodal assessment of protein functional deficiency supports pathogenicity of BRCA1 p.V1688del.

    De Nicolo A, Parisini E, Zhong Q, Dalla Palma M, Stoeckert KA, Domchek SM, Nathanson KL, Caligo MA, Vidal M, Cusick ME, Garber JE.

    Cancer Res. 2009 Sep 1;69(17):7030-7. Epub 2009 Aug 25.PMID: 19706752 [PubMed - indexed for MEDLINE]Related articles

    7.

    Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.

    Antoniou AC, Sinilnikova OM, McGuffog L, Healey S, Nevanlinna H, Heikkinen T, Simard J, Spurdle AB, Beesley J, Chen X; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Neuhausen SL, Ding YC, Couch FJ, Wang X, Fredericksen Z, Peterlongo P, Peissel B, Bonanni B, Viel A, Bernard L, Radice P, Szabo CI, Foretova L, Zikan M, Claes K, Greene MH, Mai PL, Rennert G, Lejbkowicz F, Andrulis IL, Ozcelik H, Glendon G; OCGN, Gerdes AM, Thomassen M, Sunde L, Caligo MA, Laitman Y, Kontorovich T, Cohen S, Kaufman B, Dagan E, Baruch RG, Friedman E, Harbst K, Barbany-Bustinza G, Rantala J, Ehrencrona H, Karlsson P, Domchek SM, Nathanson KL, Osorio A, Blanco I, Lasa A, Benítez J, Hamann U, Hogervorst FB, Rookus MA, Collee JM, Devilee P, Ligtenberg MJ, van der Luijt RB, Aalfs CM, Waisfisz Q, Wijnen J, van Roozendaal CE; HEBON, Peock S, Cook M, Frost D, Oliver C, Platte R, Evans DG, Lalloo F, Eeles R, Izatt L, Davidson R, Chu C, Eccles D, Cole T, Hodgson S; EMBRACE, Godwin AK, Stoppa-Lyonnet D, Buecher B, Léoné M, Bressac-de Paillerets B, Remenieras A, Caron O, Lenoir GM, Sevenet N, Longy M, Ferrer SF, Prieur F; GEMO, Goldgar D, Miron A, John EM, Buys SS, Daly MB, Hopper JL, Terry MB, Yassin Y; Breast Cancer Family Registry, Singer C, Gschwantler-Kaulich D, Staudigl C, Hansen TO, Barkardottir RB, Kirchhoff T, Pal P, Kosarin K, Offit K, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV, Toland AE, Montagna M, Casella C, Imyanitov EN, Allavena A, Schmutzler RK, Versmold B, Engel C, Meindl A, Ditsch N, Arnold N, Niederacher D, Deissler H, Fiebig B, Suttner C, Schönbuchner I, Gadzicki D, Caldes T, de la Hoya M, Pooley KA, Easton DF, Chenevix-Trench G; CIMBA.

    Hum Mol Genet. 2009 Nov 15;18(22):4442-56. Epub 2009 Aug 5.PMID: 19656774 [PubMed - in process]Related articles

    8.

    Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence.

    Shah P, Rosen M, Stopfer J, Siegfried J, Kaltman R, Mason B, Armstrong K, Nathanson KL, Schnall M, Domchek SM.

    Breast Cancer Res Treat. 2009 Dec;118(3):539-46. Epub 2009 Jul 17.PMID: 19609668 [PubMed - in process]Related articles

    9.

    Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.

    Rebbeck TR, Mitra N, Domchek SM, Wan F, Chuai S, Friebel TM, Panossian S, Spurdle A, Chenevix-Trench G; kConFab, Singer CF, Pfeiler G, Neuhausen SL, Lynch HT, Garber JE, Weitzel JN, Isaacs C, Couch F, Narod SA, Rubinstein WS, Tomlinson GE, Ganz PA, Olopade OI, Tung N, Blum JL, Greenberg R, Nathanson KL, Daly MB.

    Cancer Res. 2009 Jul 15;69(14):5801-10. Epub 2009 Jul 7.PMID: 19584272 [PubMed - indexed for MEDLINE]Related articles

    10.

    Collapse of the CD27+ B-cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancers.

    Carpenter EL, Mick R, Rech AJ, Beatty GL, Colligon TA, Rosenfeld MR, Kaplan DE, Chang KM, Domchek SM, Kanetsky PA, Fecher LA, Flaherty KT, Schuchter LM, Vonderheide RH.

    Clin Cancer Res. 2009 Jul 1;15(13):4277-87. Epub 2009 Jun 23.PMID: 19549767 [PubMed - indexed for MEDLINE]Related articles

    11.

    Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers.

    Rebbeck TR, Kauff ND, Domchek SM.

    J Natl Cancer Inst. 2009 Jan 21;101(2):80-7. Epub 2009 Jan 13.PMID: 19141781 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007.

    Schwartz GF, Hughes KS, Lynch HT, Fabian CJ, Fentiman IS, Robson ME, Domchek SM, Hartmann LC, Holland R, Winchester DJ; Consensus Conference Committee, Anderson BO, Arun BK, Bartelink H, Bernard P, Bonanni B, Cady B, Clough KB, Feig SA, Heywang-Köbrunner SH, Howell A, Isaacs C, Kopans DB, Mansel RE, Masood S, Palazzo JP, Pressman PI, Solin LJ, Untch M.

    Breast J. 2009 Jan-Feb;15(1):4-16.PMID: 19141130 [PubMed - indexed for MEDLINE]Related articles

    13.

    No evidence that GATA3 rs570613 SNP modifies breast cancer risk.

    Johnatty SE, Couch FJ, Fredericksen Z, Tarrell R, Spurdle AB, Beesley J, Chen X; kConFab Investigators; AOCS Group; Swedish BRCA1 and BRCA2 Study Collaborators, Gschwantler-Kaulich D, Singer CF, Fuerhauser C, Fink-Retter A, Domchek SM, Nathanson KL, Pankratz VS, Lindor NM, Godwin AK, Caligo MA, Hopper J, Southey MC, Giles GG, Justenhoven C, Brauch H, Hamann U, Ko YD, Heikkinen T, Aaltonen K, Aittomäki K, Blomqvist C, Nevanlinna H, Hall P, Czene K, Liu J, Peock S, Cook M, Platte R, Gareth Evans D, Lalloo F, Eeles R, Pichert G, Eccles D, Davidson R, Cole T, Cook J, Douglas F, Chu C, Hodgson S, Paterson J, Hogervorst FB, Rookus MA, Seynaeve C, Wijnen J, Vreeswijk M, Ligtenberg M, van der Luijt RB, van Os TA, Gille HJ, Blok MJ; HEBON, Issacs C, Humphreys MK, McGuffog L, Healey S, Sinilnikova O, Antoniou AC, Easton DF, Chenevix-Trench G; Breast Cancer Association Consortium and Consortium of Investigators of Modifiers of BRCA1/2.

    Breast Cancer Res Treat. 2009 Sep;117(2):371-9. Epub 2008 Dec 11.PMID: 19082709 [PubMed - indexed for MEDLINE]Related articles

    14.

    Clinical implications of low-penetrance breast cancer susceptibility alleles.

    Freisinger F, Domchek SM.

    Curr Oncol Rep. 2009 Jan;11(1):8-14. Review.PMID: 19080736 [PubMed - indexed for MEDLINE]Related articles

    15.

    Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007.

    Schwartz GF, Hughes KS, Lynch HT, Fabian CJ, Fentiman IS, Robson ME, Domchek SM, Hartmann LC, Holland R, Winchester DJ; Consensus Conference Committee The International Consensus Conference Committee.

    Cancer. 2008 Nov 15;113(10):2627-37.PMID: 18853415 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Use of total abdominal hysterectomy and hormone replacement therapy in BRCA1 and BRCA2 mutation carriers undergoing risk-reducing salpingo-oophorectomy.

    Gabriel CA, Tigges-Cardwell J, Stopfer J, Erlichman J, Nathanson K, Domchek SM.

    Fam Cancer. 2009;8(1):23-8. Epub 2008 Aug 29.PMID: 18758995 [PubMed - indexed for MEDLINE]Related articles

    17.

    Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers.

    Rebbeck TR, Domchek SM.

    Breast Cancer Res. 2008;10(4):108. Epub 2008 Jul 25.PMID: 18710587 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families.

    Palma MD, Domchek SM, Stopfer J, Erlichman J, Siegfried JD, Tigges-Cardwell J, Mason BA, Rebbeck TR, Nathanson KL.

    Cancer Res. 2008 Sep 1;68(17):7006-14. Epub 2008 Aug 14.PMID: 18703817 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriers.

    Spurdle AB, Deans AJ, Duffy D, Goldgar DE, Chen X, Beesley J; kConFaB, Easton DF, Antoniou AC, Peock S, Cook M; EMBRACE Study Collaborators, Nathanson KL, Domchek SM, MacArthur GA, Chenevix-Trench G.

    Breast Cancer Res Treat. 2009 May;115(2):307-13. Epub 2008 Jun 10.PMID: 18543099 [PubMed - indexed for MEDLINE]Related articles

    20.

    Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations.

    Finlay E, Stopfer JE, Burlingame E, Evans KG, Nathanson KL, Weber BL, Armstrong K, Rebbeck TR, Domchek SM.

    Genet Test. 2008 Mar;12(1):81-91.PMID: 18373407 [PubMed - indexed for MEDLINE]Related articles

    21.

    The clinical management of BRCA1 and BRCA2 mutation carriers.

    Gulati AP, Domchek SM.

    Curr Oncol Rep. 2008 Jan;10(1):47-53. Review.PMID: 18366960 [PubMed - indexed for MEDLINE]Related articles

    22.

    Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.

    Antoniou AC, Spurdle AB, Sinilnikova OM, Healey S, Pooley KA, Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Hofmann W, Sutter C, Niederacher D, Deissler H, Caldes T, Kämpjärvi K, Nevanlinna H, Simard J, Beesley J, Chen X; Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Neuhausen SL, Rebbeck TR, Wagner T, Lynch HT, Isaacs C, Weitzel J, Ganz PA, Daly MB, Tomlinson G, Olopade OI, Blum JL, Couch FJ, Peterlongo P, Manoukian S, Barile M, Radice P, Szabo CI, Pereira LH, Greene MH, Rennert G, Lejbkowicz F, Barnett-Griness O, Andrulis IL, Ozcelik H; OCGN, Gerdes AM, Caligo MA, Laitman Y, Kaufman B, Milgrom R, Friedman E; Swedish BRCA1 and BRCA2 study collaborators, Domchek SM, Nathanson KL, Osorio A, Llort G, Milne RL, Benítez J, Hamann U, Hogervorst FB, Manders P, Ligtenberg MJ, van den Ouweland AM; DNA-HEBON collaborators, Peock S, Cook M, Platte R, Evans DG, Eeles R, Pichert G, Chu C, Eccles D, Davidson R, Douglas F; EMBRACE, Godwin AK, Barjhoux L, Mazoyer S, Sobol H, Bourdon V, Eisinger F, Chompret A, Capoulade C, Bressac-de Paillerets B, Lenoir GM, Gauthier-Villars M, Houdayer C, Stoppa-Lyonnet D; GEMO, Chenevix-Trench G, Easton DF; CIMBA.

    Am J Hum Genet. 2008 Apr;82(4):937-48. Epub 2008 Mar 20.PMID: 18355772 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers.

    Friebel TM, Domchek SM, Neuhausen SL, Wagner T, Evans DG, Isaacs C, Garber JE, Daly MB, Eeles R, Matloff E, Tomlinson G, Lynch HT, Tung N, Blum JL, Weitzel J, Rubinstein WS, Ganz PA, Couch F, Rebbeck TR.

    Clin Breast Cancer. 2007 Dec;7(11):875-82.PMID: 18269778 [PubMed - indexed for MEDLINE]Related articles

    24.

    Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.

    Kauff ND, Domchek SM, Friebel TM, Robson ME, Lee J, Garber JE, Isaacs C, Evans DG, Lynch H, Eeles RA, Neuhausen SL, Daly MB, Matloff E, Blum JL, Sabbatini P, Barakat RR, Hudis C, Norton L, Offit K, Rebbeck TR.

    J Clin Oncol. 2008 Mar 10;26(8):1331-7. Epub 2008 Feb 11.PMID: 18268356 [PubMed - indexed for MEDLINE]Related articles

    25.

    Differential lysis of tumors by polyclonal T cell lines and T cell clones specific for hTERT.

    Chen DY, Vance BA, Thompson LB, Domchek SM, Vonderheide RH.

    Cancer Biol Ther. 2007 Dec;6(12):1991-6. Epub 2007 Sep 24.PMID: 18087213 [PubMed - indexed for MEDLINE]Related articles

    26.

    RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.

    Antoniou AC, Sinilnikova OM, Simard J, Léoné M, Dumont M, Neuhausen SL, Struewing JP, Stoppa-Lyonnet D, Barjhoux L, Hughes DJ, Coupier I, Belotti M, Lasset C, Bonadona V, Bignon YJ; Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers Study (GEMO), Rebbeck TR, Wagner T, Lynch HT, Domchek SM, Nathanson KL, Garber JE, Weitzel J, Narod SA, Tomlinson G, Olopade OI, Godwin A, Isaacs C, Jakubowska A, Lubinski J, Gronwald J, Górski B, Byrski T, Huzarski T, Peock S, Cook M, Baynes C, Murray A, Rogers M, Daly PA, Dorkins H; Epidemiological Study of BRCA1 and BRCA2 Mutation Carriers (EMBRACE), Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Niederacher D, Deissler H; German Consortium for Hereditary Breast and Ovarian Cancer (GCHBOC), Spurdle AB, Chen X, Waddell N, Cloonan N; Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab), Kirchhoff T, Offit K, Friedman E, Kaufmann B, Laitman Y, Galore G, Rennert G, Lejbkowicz F, Raskin L, Andrulis IL, Ilyushik E, Ozcelik H, Devilee P, Vreeswijk MP, Greene MH, Prindiville SA, Osorio A, Benitez J, Zikan M, Szabo CI, Kilpivaara O, Nevanlinna H, Hamann U, Durocher F, Arason A, Couch FJ, Easton DF, Chenevix-Trench G; Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

    Am J Hum Genet. 2007 Dec;81(6):1186-200. Epub 2007 Oct 16.PMID: 17999359 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Telomerase-specific T-cell immunity in breast cancer: effect of vaccination on tumor immunosurveillance.

    Domchek SM, Recio A, Mick R, Clark CE, Carpenter EL, Fox KR, DeMichele A, Schuchter LM, Leibowitz MS, Wexler MH, Vance BA, Beatty GL, Veloso E, Feldman MD, Vonderheide RH.

    Cancer Res. 2007 Nov 1;67(21):10546-55.PMID: 17974999 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    The prevention of hereditary breast cancer.

    Rodriquez E, Domchek SM.

    Semin Oncol. 2007 Oct;34(5):401-5. Review.PMID: 17920894 [PubMed - indexed for MEDLINE]Related articles

    29.

    Cancer risk models: translating family history into clinical management.

    Domchek SM, Antoniou A.

    Ann Intern Med. 2007 Oct 2;147(7):515-7. No abstract available. PMID: 17909212 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study.

    Lehman CD, Isaacs C, Schnall MD, Pisano ED, Ascher SM, Weatherall PT, Bluemke DA, Bowen DJ, Marcom PK, Armstrong DK, Domchek SM, Tomlinson G, Skates SJ, Gatsonis C.

    Radiology. 2007 Aug;244(2):381-8.PMID: 17641362 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Prophylactic oophorectomy in women at increased cancer risk.

    Domchek SM, Rebbeck TR.

    Curr Opin Obstet Gynecol. 2007 Feb;19(1):27-30. Review.PMID: 17218848 [PubMed - indexed for MEDLINE]Related articles

    32.

    Clinical management of BRCA1 and BRCA2 mutation carriers.

    Domchek SM, Weber BL.

    Oncogene. 2006 Sep 25;25(43):5825-31. Review.PMID: 16998496 [PubMed - indexed for MEDLINE]Related articles

    33.

    Childhood cancer in families with and without BRCA1 or BRCA2 mutations ascertained at a high-risk breast cancer clinic.

    Brooks GA, Stopfer JE, Erlichman J, Davidson R, Nathanson KL, Domchek SM.

    Cancer Biol Ther. 2006 Sep;5(9):1098-102. Epub 2006 Sep 11.PMID: 16931905 [PubMed - indexed for MEDLINE]Related articles

    34.

    Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study.

    Domchek SM, Friebel TM, Neuhausen SL, Wagner T, Evans G, Isaacs C, Garber JE, Daly MB, Eeles R, Matloff E, Tomlinson GE, Van't Veer L, Lynch HT, Olopade OI, Weber BL, Rebbeck TR.

    Lancet Oncol. 2006 Mar;7(3):223-9.PMID: 16510331 [PubMed - indexed for MEDLINE]Related articles

    35.

    Bilateral risk-reducing oophorectomy in BRCA1 and BRCA2 mutation carriers.

    Domchek SM, Stopfer JE, Rebbeck TR.

    J Natl Compr Canc Netw. 2006 Feb;4(2):177-82. Review.PMID: 16451773 [PubMed - indexed for MEDLINE]Related articles

    36.

    Clinical management of BRCA1 and BRCA2 mutation carriers.

    Domchek SM, Armstrong K, Weber BL.

    Nat Clin Pract Oncol. 2006 Jan;3(1):2-3. No abstract available. PMID: 16407858 [PubMed - indexed for MEDLINE]Related articles

    37.

    Telomerase vaccination has no detectable effect on SCID-repopulating and colony-forming activities in the bone marrow of cancer patients.

    Danet-Desnoyers GA, Luongo JL, Bonnet DA, Domchek SM, Vonderheide RH.

    Exp Hematol. 2005 Nov;33(11):1275-80.PMID: 16263411 [PubMed - indexed for MEDLINE]Related articles

    38.

    Sex ratio skewing of offspring in families with hereditary susceptibility to breast cancer.

    Domchek SM, Merillat SL, Tigges J, Tweed AJ, Weinar M, Stopfer J, Weber BL.

    J Med Genet. 2005 Jun;42(6):511-3. No abstract available. PMID: 15937087 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Knowledge, attitudes, and utilization of BRCA1/2 testing among women with early-onset breast cancer.

    Peters N, Domchek SM, Rose A, Polis R, Stopfer J, Armstrong K.

    Genet Test. 2005 Spring;9(1):48-53. Erratum in: Genet Test. 2005 Winter;9(4):342. Domcheck, Susan M [corrected to Domchek, Susan M]. PMID: 15857187 [PubMed - indexed for MEDLINE]Related articles

    41.

    Germline CHEK2*1100delC mutations in breast cancer patients with multiple primary cancers.

    Huang J, Domchek SM, Brose MS, Rebbeck TR, Nathanson KL, Weber BL.

    J Med Genet. 2004 Nov;41(11):e120. No abstract available. PMID: 15520402 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes.

    Vonderheide RH, Domchek SM, Schultze JL, George DJ, Hoar KM, Chen DY, Stephans KF, Masutomi K, Loda M, Xia Z, Anderson KS, Hahn WC, Nadler LM.

    Clin Cancer Res. 2004 Feb 1;10(3):828-39.PMID: 14871958 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.

    Bendell JC, Domchek SM, Burstein HJ, Harris L, Younger J, Kuter I, Bunnell C, Rue M, Gelman R, Winer E.

    Cancer. 2003 Jun 15;97(12):2972-7.PMID: 12784331 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Application of breast cancer risk prediction models in clinical practice.

    Domchek SM, Eisen A, Calzone K, Stopfer J, Blackwood A, Weber BL.

    J Clin Oncol. 2003 Feb 15;21(4):593-601. Review.PMID: 12586794 [PubMed - indexed for MEDLINE]Related articles

    45.

    Recent advances in breast cancer biology.

    Domchek SM, Weber BL.

    Curr Opin Oncol. 2002 Nov;14(6):589-93. Review.PMID: 12409647 [PubMed - indexed for MEDLINE]Related articles

    46.

    The utility of ductal lavage in breast cancer detection and risk assessment.

    Domchek SM.

    Breast Cancer Res. 2002;4(2):51-3. Epub 2002 Feb 1.PMID: 11879562 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Lymphomas of the breast: primary and secondary involvement.

    Domchek SM, Hecht JL, Fleming MD, Pinkus GS, Canellos GP.

    Cancer. 2002 Jan 1;94(1):6-13.PMID: 11815954 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Predictors of skeletal complications in patients with metastatic breast carcinoma.

    Domchek SM, Younger J, Finkelstein DM, Seiden MV.

    Cancer. 2000 Jul 15;89(2):363-8.PMID: 10918167 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Phosphatidylinositol 3-kinase p85 SH2 domain specificity defined by direct phosphopeptide/SH2 domain binding.

    Piccione E, Case RD, Domchek SM, Hu P, Chaudhuri M, Backer JM, Schlessinger J, Shoelson SE.

    Biochemistry. 1993 Apr 6;32(13):3197-202.PMID: 8384875 [PubMed - indexed for MEDLINE]Related articles

    50.

    Inhibition of SH2 domain/phosphoprotein association by a nonhydrolyzable phosphonopeptide.

    Domchek SM, Auger KR, Chatterjee S, Burke TR Jr, Shoelson SE.

    Biochemistry. 1992 Oct 20;31(41):9865-70.PMID: 1382595 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...